Edition:
United States

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

43.83USD
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
$43.83
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,388
52-wk High
$58.36
52-wk Low
$38.12

Chart for

About

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $309.78
Shares Outstanding(Mil.): 7.19
Dividend: --
Yield (%): --

Financials

  BSTC.OQ Industry Sector
P/E (TTM): 25.33 200.91 33.50
EPS (TTM): 1.70 -- --
ROI: 18.34 -0.75 13.17
ROE: 20.08 -2.86 14.98

BRIEF-Biospecifics Technologies Q4 Earnings Per Share $0.36

* . REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 14 2018

BRIEF-Biospecifics Technologies reports Q3 eps of $0.37

* Biospecifics Technologies Corp reports Q3 2017 financial results

Nov 10 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $127.55 -0.17
Novartis AG (NOVN.S) CHF76.88 -0.40
Pfizer Inc. (PFE.N) $36.53 +0.04
Roche Holding Ltd. (ROG.S) CHF216.50 0.00
Roche Holding Ltd. (RO.S) CHF220.00 -0.20
Merck & Co., Inc. (MRK.N) $58.64 -0.28
Bayer AG (BAYGn.DE) €99.59 -0.01
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €65.25 -0.35
GlaxoSmithKline plc (GSK.L) 1,419.60 +12.20

Earnings vs. Estimates